Global Drugs for Enuresis Market Growth 2025-2031

March 2025 | 88 pages | ID: G324E24C1649EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Drugs for Enuresis market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The drugs used to treat enuresis are mainly stimulants of central nervous system or antidiuretic hormones

United States market for Drugs for Enuresis is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Drugs for Enuresis is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Drugs for Enuresis is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Drugs for Enuresis players cover Allergan, Ferring Pharmaceuticals, Inc., Pfizer Inc., Janssen Pharmaceuticals, Inc., Urovant Sciences, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Drugs for Enuresis Industry Forecast” looks at past sales and reviews total world Drugs for Enuresis sales in 2024, providing a comprehensive analysis by region and market sector of projected Drugs for Enuresis sales for 2025 through 2031. With Drugs for Enuresis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drugs for Enuresis industry.

This Insight Report provides a comprehensive analysis of the global Drugs for Enuresis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drugs for Enuresis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drugs for Enuresis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drugs for Enuresis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drugs for Enuresis.

This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Enuresis market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Anticholinergic Drugs
• Tricyclic Antidepressants
• Desmopressin

Segmentation by Application:

• Hospital
• Specialist Clinic
• Othere

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Allergan
• Ferring Pharmaceuticals, Inc.
• Pfizer Inc.
• Janssen Pharmaceuticals, Inc.
• Urovant Sciences, Inc.
• Astellas Pharma US, Inc.
• Bayer Corp
• Mallinckrodt, Inc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Drugs for Enuresis market?

What factors are driving Drugs for Enuresis market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Drugs for Enuresis market opportunities vary by end market size?

How does Drugs for Enuresis break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Drugs for Enuresis Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Drugs for Enuresis by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Drugs for Enuresis by Country/Region, 2020, 2024 & 2031
2.2 Drugs for Enuresis Segment by Type
  2.2.1 Anticholinergic Drugs
  2.2.2 Tricyclic Antidepressants
  2.2.3 Desmopressin
2.3 Drugs for Enuresis Sales by Type
  2.3.1 Global Drugs for Enuresis Sales Market Share by Type (2020-2025)
  2.3.2 Global Drugs for Enuresis Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Drugs for Enuresis Sale Price by Type (2020-2025)
2.4 Drugs for Enuresis Segment by Application
  2.4.1 Hospital
  2.4.2 Specialist Clinic
  2.4.3 Othere
2.5 Drugs for Enuresis Sales by Application
  2.5.1 Global Drugs for Enuresis Sale Market Share by Application (2020-2025)
  2.5.2 Global Drugs for Enuresis Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Drugs for Enuresis Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Drugs for Enuresis Breakdown Data by Company
  3.1.1 Global Drugs for Enuresis Annual Sales by Company (2020-2025)
  3.1.2 Global Drugs for Enuresis Sales Market Share by Company (2020-2025)
3.2 Global Drugs for Enuresis Annual Revenue by Company (2020-2025)
  3.2.1 Global Drugs for Enuresis Revenue by Company (2020-2025)
  3.2.2 Global Drugs for Enuresis Revenue Market Share by Company (2020-2025)
3.3 Global Drugs for Enuresis Sale Price by Company
3.4 Key Manufacturers Drugs for Enuresis Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Drugs for Enuresis Product Location Distribution
  3.4.2 Players Drugs for Enuresis Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR DRUGS FOR ENURESIS BY GEOGRAPHIC REGION

4.1 World Historic Drugs for Enuresis Market Size by Geographic Region (2020-2025)
  4.1.1 Global Drugs for Enuresis Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Drugs for Enuresis Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Drugs for Enuresis Market Size by Country/Region (2020-2025)
  4.2.1 Global Drugs for Enuresis Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Drugs for Enuresis Annual Revenue by Country/Region (2020-2025)
4.3 Americas Drugs for Enuresis Sales Growth
4.4 APAC Drugs for Enuresis Sales Growth
4.5 Europe Drugs for Enuresis Sales Growth
4.6 Middle East & Africa Drugs for Enuresis Sales Growth

5 AMERICAS

5.1 Americas Drugs for Enuresis Sales by Country
  5.1.1 Americas Drugs for Enuresis Sales by Country (2020-2025)
  5.1.2 Americas Drugs for Enuresis Revenue by Country (2020-2025)
5.2 Americas Drugs for Enuresis Sales by Type (2020-2025)
5.3 Americas Drugs for Enuresis Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Drugs for Enuresis Sales by Region
  6.1.1 APAC Drugs for Enuresis Sales by Region (2020-2025)
  6.1.2 APAC Drugs for Enuresis Revenue by Region (2020-2025)
6.2 APAC Drugs for Enuresis Sales by Type (2020-2025)
6.3 APAC Drugs for Enuresis Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Drugs for Enuresis by Country
  7.1.1 Europe Drugs for Enuresis Sales by Country (2020-2025)
  7.1.2 Europe Drugs for Enuresis Revenue by Country (2020-2025)
7.2 Europe Drugs for Enuresis Sales by Type (2020-2025)
7.3 Europe Drugs for Enuresis Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Drugs for Enuresis by Country
  8.1.1 Middle East & Africa Drugs for Enuresis Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Drugs for Enuresis Revenue by Country (2020-2025)
8.2 Middle East & Africa Drugs for Enuresis Sales by Type (2020-2025)
8.3 Middle East & Africa Drugs for Enuresis Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drugs for Enuresis
10.3 Manufacturing Process Analysis of Drugs for Enuresis
10.4 Industry Chain Structure of Drugs for Enuresis

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Drugs for Enuresis Distributors
11.3 Drugs for Enuresis Customer

12 WORLD FORECAST REVIEW FOR DRUGS FOR ENURESIS BY GEOGRAPHIC REGION

12.1 Global Drugs for Enuresis Market Size Forecast by Region
  12.1.1 Global Drugs for Enuresis Forecast by Region (2026-2031)
  12.1.2 Global Drugs for Enuresis Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Drugs for Enuresis Forecast by Type (2026-2031)
12.7 Global Drugs for Enuresis Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Allergan
  13.1.1 Allergan Company Information
  13.1.2 Allergan Drugs for Enuresis Product Portfolios and Specifications
  13.1.3 Allergan Drugs for Enuresis Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Allergan Main Business Overview
  13.1.5 Allergan Latest Developments
13.2 Ferring Pharmaceuticals, Inc.
  13.2.1 Ferring Pharmaceuticals, Inc. Company Information
  13.2.2 Ferring Pharmaceuticals, Inc. Drugs for Enuresis Product Portfolios and Specifications
  13.2.3 Ferring Pharmaceuticals, Inc. Drugs for Enuresis Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Ferring Pharmaceuticals, Inc. Main Business Overview
  13.2.5 Ferring Pharmaceuticals, Inc. Latest Developments
13.3 Pfizer Inc.
  13.3.1 Pfizer Inc. Company Information
  13.3.2 Pfizer Inc. Drugs for Enuresis Product Portfolios and Specifications
  13.3.3 Pfizer Inc. Drugs for Enuresis Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Pfizer Inc. Main Business Overview
  13.3.5 Pfizer Inc. Latest Developments
13.4 Janssen Pharmaceuticals, Inc.
  13.4.1 Janssen Pharmaceuticals, Inc. Company Information
  13.4.2 Janssen Pharmaceuticals, Inc. Drugs for Enuresis Product Portfolios and Specifications
  13.4.3 Janssen Pharmaceuticals, Inc. Drugs for Enuresis Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Janssen Pharmaceuticals, Inc. Main Business Overview
  13.4.5 Janssen Pharmaceuticals, Inc. Latest Developments
13.5 Urovant Sciences, Inc.
  13.5.1 Urovant Sciences, Inc. Company Information
  13.5.2 Urovant Sciences, Inc. Drugs for Enuresis Product Portfolios and Specifications
  13.5.3 Urovant Sciences, Inc. Drugs for Enuresis Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Urovant Sciences, Inc. Main Business Overview
  13.5.5 Urovant Sciences, Inc. Latest Developments
13.6 Astellas Pharma US, Inc.
  13.6.1 Astellas Pharma US, Inc. Company Information
  13.6.2 Astellas Pharma US, Inc. Drugs for Enuresis Product Portfolios and Specifications
  13.6.3 Astellas Pharma US, Inc. Drugs for Enuresis Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Astellas Pharma US, Inc. Main Business Overview
  13.6.5 Astellas Pharma US, Inc. Latest Developments
13.7 Bayer Corp
  13.7.1 Bayer Corp Company Information
  13.7.2 Bayer Corp Drugs for Enuresis Product Portfolios and Specifications
  13.7.3 Bayer Corp Drugs for Enuresis Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Bayer Corp Main Business Overview
  13.7.5 Bayer Corp Latest Developments
13.8 Mallinckrodt, Inc.
  13.8.1 Mallinckrodt, Inc. Company Information
  13.8.2 Mallinckrodt, Inc. Drugs for Enuresis Product Portfolios and Specifications
  13.8.3 Mallinckrodt, Inc. Drugs for Enuresis Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Mallinckrodt, Inc. Main Business Overview
  13.8.5 Mallinckrodt, Inc. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Drugs for Enuresis Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Drugs for Enuresis Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Anticholinergic Drugs
Table 4. Major Players ofTricyclic Antidepressants
Table 5. Major Players of Desmopressin
Table 6. Global Drugs for Enuresis Sales byType (2020-2025) & (K Units)
Table 7. Global Drugs for Enuresis Sales Market Share byType (2020-2025)
Table 8. Global Drugs for Enuresis Revenue byType (2020-2025) & ($ million)
Table 9. Global Drugs for Enuresis Revenue Market Share byType (2020-2025)
Table 10. Global Drugs for Enuresis Sale Price byType (2020-2025) & (US$/Unit)
Table 11. Global Drugs for Enuresis Sale by Application (2020-2025) & (K Units)
Table 12. Global Drugs for Enuresis Sale Market Share by Application (2020-2025)
Table 13. Global Drugs for Enuresis Revenue by Application (2020-2025) & ($ million)
Table 14. Global Drugs for Enuresis Revenue Market Share by Application (2020-2025)
Table 15. Global Drugs for Enuresis Sale Price by Application (2020-2025) & (US$/Unit)
Table 16. Global Drugs for Enuresis Sales by Company (2020-2025) & (K Units)
Table 17. Global Drugs for Enuresis Sales Market Share by Company (2020-2025)
Table 18. Global Drugs for Enuresis Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Drugs for Enuresis Revenue Market Share by Company (2020-2025)
Table 20. Global Drugs for Enuresis Sale Price by Company (2020-2025) & (US$/Unit)
Table 21. Key Manufacturers Drugs for Enuresis Producing Area Distribution and Sales Area
Table 22. Players Drugs for Enuresis Products Offered
Table 23. Drugs for Enuresis Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Drugs for Enuresis Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Drugs for Enuresis Sales Market Share Geographic Region (2020-2025)
Table 28. Global Drugs for Enuresis Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Drugs for Enuresis Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Drugs for Enuresis Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Drugs for Enuresis Sales Market Share by Country/Region (2020-2025)
Table 32. Global Drugs for Enuresis Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Drugs for Enuresis Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Drugs for Enuresis Sales by Country (2020-2025) & (K Units)
Table 35. Americas Drugs for Enuresis Sales Market Share by Country (2020-2025)
Table 36. Americas Drugs for Enuresis Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Drugs for Enuresis Sales byType (2020-2025) & (K Units)
Table 38. Americas Drugs for Enuresis Sales by Application (2020-2025) & (K Units)
Table 39. APAC Drugs for Enuresis Sales by Region (2020-2025) & (K Units)
Table 40. APAC Drugs for Enuresis Sales Market Share by Region (2020-2025)
Table 41. APAC Drugs for Enuresis Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Drugs for Enuresis Sales byType (2020-2025) & (K Units)
Table 43. APAC Drugs for Enuresis Sales by Application (2020-2025) & (K Units)
Table 44. Europe Drugs for Enuresis Sales by Country (2020-2025) & (K Units)
Table 45. Europe Drugs for Enuresis Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Drugs for Enuresis Sales byType (2020-2025) & (K Units)
Table 47. Europe Drugs for Enuresis Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Drugs for Enuresis Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Drugs for Enuresis Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Drugs for Enuresis Sales byType (2020-2025) & (K Units)
Table 51. Middle East & Africa Drugs for Enuresis Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Drugs for Enuresis
Table 53. Key Market Challenges & Risks of Drugs for Enuresis
Table 54. Key IndustryTrends of Drugs for Enuresis
Table 55. Drugs for Enuresis Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Drugs for Enuresis Distributors List
Table 58. Drugs for Enuresis Customer List
Table 59. Global Drugs for Enuresis SalesForecast by Region (2026-2031) & (K Units)
Table 60. Global Drugs for Enuresis RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Drugs for Enuresis SalesForecast by Country (2026-2031) & (K Units)
Table 62. Americas Drugs for Enuresis Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Drugs for Enuresis SalesForecast by Region (2026-2031) & (K Units)
Table 64. APAC Drugs for Enuresis Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Drugs for Enuresis SalesForecast by Country (2026-2031) & (K Units)
Table 66. Europe Drugs for Enuresis RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Drugs for Enuresis SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Drugs for Enuresis RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Drugs for Enuresis SalesForecast byType (2026-2031) & (K Units)
Table 70. Global Drugs for Enuresis RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Drugs for Enuresis SalesForecast by Application (2026-2031) & (K Units)
Table 72. Global Drugs for Enuresis RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Allergan Basic Information, Drugs for Enuresis Manufacturing Base, Sales Area and Its Competitors
Table 74. Allergan Drugs for Enuresis Product Portfolios and Specifications
Table 75. Allergan Drugs for Enuresis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Allergan Main Business
Table 77. Allergan Latest Developments
Table 78.Ferring Pharmaceuticals, Inc. Basic Information, Drugs for Enuresis Manufacturing Base, Sales Area and Its Competitors
Table 79.Ferring Pharmaceuticals, Inc. Drugs for Enuresis Product Portfolios and Specifications
Table 80.Ferring Pharmaceuticals, Inc. Drugs for Enuresis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81.Ferring Pharmaceuticals, Inc. Main Business
Table 82.Ferring Pharmaceuticals, Inc. Latest Developments
Table 83. Pfizer Inc. Basic Information, Drugs for Enuresis Manufacturing Base, Sales Area and Its Competitors
Table 84. Pfizer Inc. Drugs for Enuresis Product Portfolios and Specifications
Table 85. Pfizer Inc. Drugs for Enuresis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Pfizer Inc. Main Business
Table 87. Pfizer Inc. Latest Developments
Table 88. Janssen Pharmaceuticals, Inc. Basic Information, Drugs for Enuresis Manufacturing Base, Sales Area and Its Competitors
Table 89. Janssen Pharmaceuticals, Inc. Drugs for Enuresis Product Portfolios and Specifications
Table 90. Janssen Pharmaceuticals, Inc. Drugs for Enuresis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Janssen Pharmaceuticals, Inc. Main Business
Table 92. Janssen Pharmaceuticals, Inc. Latest Developments
Table 93. Urovant Sciences, Inc. Basic Information, Drugs for Enuresis Manufacturing Base, Sales Area and Its Competitors
Table 94. Urovant Sciences, Inc. Drugs for Enuresis Product Portfolios and Specifications
Table 95. Urovant Sciences, Inc. Drugs for Enuresis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Urovant Sciences, Inc. Main Business
Table 97. Urovant Sciences, Inc. Latest Developments
Table 98. Astellas Pharma US, Inc. Basic Information, Drugs for Enuresis Manufacturing Base, Sales Area and Its Competitors
Table 99. Astellas Pharma US, Inc. Drugs for Enuresis Product Portfolios and Specifications
Table 100. Astellas Pharma US, Inc. Drugs for Enuresis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Astellas Pharma US, Inc. Main Business
Table 102. Astellas Pharma US, Inc. Latest Developments
Table 103. Bayer Corp Basic Information, Drugs for Enuresis Manufacturing Base, Sales Area and Its Competitors
Table 104. Bayer Corp Drugs for Enuresis Product Portfolios and Specifications
Table 105. Bayer Corp Drugs for Enuresis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Bayer Corp Main Business
Table 107. Bayer Corp Latest Developments
Table 108. Mallinckrodt, Inc. Basic Information, Drugs for Enuresis Manufacturing Base, Sales Area and Its Competitors
Table 109. Mallinckrodt, Inc. Drugs for Enuresis Product Portfolios and Specifications
Table 110. Mallinckrodt, Inc. Drugs for Enuresis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. Mallinckrodt, Inc. Main Business
Table 112. Mallinckrodt, Inc. Latest Developments



LIST OFFIGURES

Figure 1. Picture of Drugs for Enuresis
Figure 2. Drugs for Enuresis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drugs for Enuresis Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Drugs for Enuresis Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Drugs for Enuresis Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Drugs for Enuresis Sales Market Share by Country/Region (2024)
Figure 10. Drugs for Enuresis Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Anticholinergic Drugs
Figure 12. Product Picture ofTricyclic Antidepressants
Figure 13. Product Picture of Desmopressin
Figure 14. Global Drugs for Enuresis Sales Market Share byType in 2025
Figure 15. Global Drugs for Enuresis Revenue Market Share byType (2020-2025)
Figure 16. Drugs for Enuresis Consumed in Hospital
Figure 17. Global Drugs for Enuresis Market: Hospital (2020-2025) & (K Units)
Figure 18. Drugs for Enuresis Consumed in Specialist Clinic
Figure 19. Global Drugs for Enuresis Market: Specialist Clinic (2020-2025) & (K Units)
Figure 20. Drugs for Enuresis Consumed in Othere
Figure 21. Global Drugs for Enuresis Market: Othere (2020-2025) & (K Units)
Figure 22. Global Drugs for Enuresis Sale Market Share by Application (2024)
Figure 23. Global Drugs for Enuresis Revenue Market Share by Application in 2025
Figure 24. Drugs for Enuresis Sales by Company in 2025 (K Units)
Figure 25. Global Drugs for Enuresis Sales Market Share by Company in 2025
Figure 26. Drugs for Enuresis Revenue by Company in 2025 ($ millions)
Figure 27. Global Drugs for Enuresis Revenue Market Share by Company in 2025
Figure 28. Global Drugs for Enuresis Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Drugs for Enuresis Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Drugs for Enuresis Sales 2020-2025 (K Units)
Figure 31. Americas Drugs for Enuresis Revenue 2020-2025 ($ millions)
Figure 32. APAC Drugs for Enuresis Sales 2020-2025 (K Units)
Figure 33. APAC Drugs for Enuresis Revenue 2020-2025 ($ millions)
Figure 34. Europe Drugs for Enuresis Sales 2020-2025 (K Units)
Figure 35. Europe Drugs for Enuresis Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Drugs for Enuresis Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Drugs for Enuresis Revenue 2020-2025 ($ millions)
Figure 38. Americas Drugs for Enuresis Sales Market Share by Country in 2025
Figure 39. Americas Drugs for Enuresis Revenue Market Share by Country (2020-2025)
Figure 40. Americas Drugs for Enuresis Sales Market Share byType (2020-2025)
Figure 41. Americas Drugs for Enuresis Sales Market Share by Application (2020-2025)
Figure 42. United States Drugs for Enuresis Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Drugs for Enuresis Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Drugs for Enuresis Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Drugs for Enuresis Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Drugs for Enuresis Sales Market Share by Region in 2025
Figure 47. APAC Drugs for Enuresis Revenue Market Share by Region (2020-2025)
Figure 48. APAC Drugs for Enuresis Sales Market Share byType (2020-2025)
Figure 49. APAC Drugs for Enuresis Sales Market Share by Application (2020-2025)
Figure 50. China Drugs for Enuresis Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Drugs for Enuresis Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Drugs for Enuresis Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Drugs for Enuresis Revenue Growth 2020-2025 ($ millions)
Figure 54. India Drugs for Enuresis Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Drugs for Enuresis Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Drugs for Enuresis Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Drugs for Enuresis Sales Market Share by Country in 2025
Figure 58. Europe Drugs for Enuresis Revenue Market Share by Country (2020-2025)
Figure 59. Europe Drugs for Enuresis Sales Market Share byType (2020-2025)
Figure 60. Europe Drugs for Enuresis Sales Market Share by Application (2020-2025)
Figure 61. Germany Drugs for Enuresis Revenue Growth 2020-2025 ($ millions)
Figure 62.France Drugs for Enuresis Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Drugs for Enuresis Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Drugs for Enuresis Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Drugs for Enuresis Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Drugs for Enuresis Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Drugs for Enuresis Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Drugs for Enuresis Sales Market Share by Application (2020-2025)
Figure 69. Egypt Drugs for Enuresis Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Drugs for Enuresis Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Drugs for Enuresis Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Drugs for Enuresis Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Drugs for Enuresis Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Drugs for Enuresis in 2025
Figure 75. Manufacturing Process Analysis of Drugs for Enuresis
Figure 76. Industry Chain Structure of Drugs for Enuresis
Figure 77. Channels of Distribution
Figure 78. Global Drugs for Enuresis Sales MarketForecast by Region (2026-2031)
Figure 79. Global Drugs for Enuresis Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Drugs for Enuresis Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Drugs for Enuresis Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Drugs for Enuresis Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Drugs for Enuresis Revenue Market ShareForecast by Application (2026-2031)